Results 1 to 10 of about 267,863 (253)

High-content CRISPR screening in tumor immunology [PDF]

Frontiers in Immunology, 2022
CRISPR screening is a powerful tool that links specific genetic alterations to corresponding phenotypes, thus allowing for high-throughput identification of novel gene functions.
Erin A. Holcomb, Erin A. Holcomb, Ashley N. Pearson, Ashley N. Pearson, Kassidy M. Jungles, Kassidy M. Jungles, Kassidy M. Jungles, Akshay Tate, Jadyn James, Long Jiang, Long Jiang, Amanda K. Huber, Michael D. Green, Michael D. Green, Michael D. Green, Michael D. Green, Michael D. Green   +16 more
doaj   +4 more sources

Imaging in Tumor Immunology. [PDF]

Nucl Med Mol Imaging, 2021
Recent advances in immune modulation have made impressive progress in cancer immunotherapy. Because dynamic nature of the immune response often makes it difficult to evaluate therapeutic outcomes, innovative imaging technologies have been developed to enable non-invasive visualization of immune cells and tumors in their microenvironment.
Kim EE, Youn H, Kang KW.
europepmc   +3 more sources

Editorial: New Insights into the Complexity of Tumor Immunology in B-cell Malignancies: Tumor Immunology and Immunotherapy [PDF]

Frontiers in Oncology, 2022
Martina Seiffert, Etienne Moussay, Jérôme Paggetti   +2 more
doaj   +2 more sources

Epigenetics of Dendritic Cells in Tumor Immunology [PDF]

Cancers, 2022
Esteban Ballestar, Godoy-Tena Gérard, Ballestar Esteban   +2 more
exaly   +2 more sources

Roles for the FCRL6 Immunoreceptor in Tumor Immunology [PDF]

Frontiers in Immunology, 2020
Randall Davis, Davis Randall S
exaly   +2 more sources

Duality of B Cell-CXCL13 Axis in Tumor Immunology [PDF]

Frontiers in Immunology, 2020
Tyrone Porter, Xuemei Zhong, Zhong Xuemei   +2 more
exaly   +2 more sources

The Role of Autophagy in Tumor Immunology—Complex Mechanisms That May Be Explored Therapeutically [PDF]

Frontiers in Oncology, 2020
Patricia Savio De Araújo-Souza, Lepique Ap, Leticia Boslooper Gonçalves   +2 more
exaly   +2 more sources

Tumor Immunology [PDF]

Immunity, 1998
Marcus E. Peter, Peter H. Krammer, Wulf Dröge   +2 more
exaly   +3 more sources

KLF4-mediated upregulation of the NKG2D ligand MICA in acute myeloid leukemia: a novel therapeutic target identified by enChIP

Cell Communication and Signaling, 2023
The immunoreceptor NKG2D, which is expressed on NK cells and T cell subsets is critically involved in tumor immune surveillance. This applies in particular to acute myeloid leukemia (AML), which evades immune detection by downregulation of NKG2D ligands (
Reem Alkhayer, Viviane Ponath, Miriam Frech, Till Adhikary, Johannes Graumann, Andreas Neubauer, Elke Pogge von Strandmann   +6 more
doaj   +1 more source

Neoadjuvant immune checkpoint blockade triggers persistent and systemic Treg activation which blunts therapeutic efficacy against metastatic spread of breast tumors

OncoImmunology, 2023
The clinical successes of immune checkpoint blockade (ICB) in advanced cancer patients have recently spurred the clinical implementation of ICB in the neoadjuvant and perioperative setting. However, how neoadjuvant ICB therapy affects the systemic immune
Olga S. Blomberg, Kevin Kos, Lorenzo Spagnuolo, Olga I. Isaeva, Hannah Garner, Max D. Wellenstein, Noor Bakker, Danique E.M. Duits, Kelly Kersten, Sjoerd Klarenbeek, Cheei-Sing Hau, Daphne Kaldenbach, Elisabeth A.M. Raeven, Kim Vrijland, Marleen Kok, Karin E. de Visser   +15 more
doaj   +1 more source